KetoBIOTIC - Advanced Probiotic Formula

KetoBIOTIC - Advanced Probiotic featuring DE111™ (Bacillus subtilis)

Low carb and ketogenic diets can reduce the beneficial bacteria in the gut because of the lack of probiotic rich foods. Most foods that contain ample amount of probiotics typically contain carbs and sugar such as yogurt, sugary drinks etc. This reduction in probiotics/healthy gut bacteria could lead to a lot of unwanted side effects such as constipation, inflammation, lowered immune system and more. Probiotics are not only ideal for a person who follows a low carb/ketogenic diet but for anyone interested in supporting ideal immune system function, improve digestion, avoid inflammation and more.

Ingredients:

Probiotic Bacteria:  5.75 Billion Organisms
Consisting of:
DE111™ (Bacillus subtilis)
Lactobacillus rhamnosus
Lactobacillus casei
Bifidobacterium longum
Lactobacillus acidophilus
Lactobacillus plantarum
Bifidobacterium breve

Supports:

• Digestive and intestinal health
• Immune system health
• Healthy gut flora

DE111® probiotic is clinically proven to support a healthy gut flora by controlling microbial populations, and promoting proper digestion of dietary fats and complex carbohydrates into beneficial small chain fatty acids such as omega-3 and omega-6, while maintaining healthy levels of cholesterol, glucose and triglycerides.

KetoBIOTIC - Advanced Probiotic provide living microorganisms which are thought to be beneficial, if not essential for overall health and well being. Specifically, Probiotics are recognized for their benefits in promoting a healthy digestive tract and immune system including the reduction of pathogens responsible for diarrhea and the restoration of microflora in the intestinal tract following the use of antibiotics.

KetoBIOTIC Advanced Probiotic formula provides more than 5 billion living microorganisms at the time of manufacturing and offers an effective blend of the following key probiotics:

Lactobacillus acidophilus: L. acidophilus is characterized as being a rod shaped motile bacteria that grows in or without the presence of oxygen. L. acidophilus is also characterized as a homofermentative that only produces lactic acid as its sole product. L. acidophilus is naturally found in the human and animal GI tract, mouth and vagina.

Lactobacillus rhamnosus: L. rhamnosus is gaining recognition for its systemic immune-enhancing ability and is known to produce the biologically desirable L(+) lactic acid Lactobacillus plantarum.

Lactobacillus plantarum: The ability of L. plantarum to produce antimicrobial substances helps them survive in the gastro-intestinal tract of humans. The antimicrobial substances produced have shown significant effect on Gram-positive and Gram-negative bacteria.

Bifidobacterium longum: Bifidobacterium longum is one of most important inhabitants in the human body. This bacterium is very helpful because it maintains a normal digestive tract, inhibits the growth of harmful bacteria, and also boosts the immune system.

Bifidobacterium breve: B breve, this bacteria is anaerobic and non-motile. Its branches are rod-shaped, looking almost like a cactus in the microscopic view.

Bacillus subtilus: A member of the genus Bacillus, B. subtilis is rod-shaped, and has the ability to form a tough, protective endospore, allowing the organism to tolerate extreme environmental conditions. B. subtilis has a long history of use in treating gastrointestinal disorders such as dysentery. It is known to stimulate the immune system and produce antibiotic compounds that inhibit the growth of some pathogenic microorganisms.




References:

 April 2015 The FASEB Journal vol. 29 no. 1 Supplement 924.33 Biology University of Wisconsin - La Crosse La Crosse WI United States Tolerance and Efficacy of a Probiotic Supplement Delivered in Capsule Form

- Denipote FG, Trindade EB, Burini RC. Probiotics and prebiotics in primary care for colon cancer. Arq Gastroenterol. 2010 Jan-Mar;47(1):93-8. - Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev. 2011 Apr;12(4):272-81.

- Girardin M, Seidman EG. Indications for the use of probiotics in gastrointestinal diseases. Dig Dis. 2011;29(6):574-87.

- Ly NP, Litonjua A, Gold DR, Celedon JC. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol. 2011 May;127(5):1087-94; quiz 95-6.

- Rauch M, Lynch S. The potential for probiotic manipulation of the gastrointestinal microbiome. Curr Opin Biotechnol. 2011 Nov 30.


These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.